This list is an analysis based on recent market events. It's not an investment recommendation.
About
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.
The current price of MBX is $60.93 USD — it has decreased by -1.09% in the past 24 hours. Watch MBX Biosciences stock price performance more closely on the chart.
What is MBX Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange MBX Biosciences stocks are traded under the ticker MBX.
Is MBX Biosciences stock price growing?▼
MBX stock has fallen by -8.73% compared to the previous week, the month change is a -7.58% fall, over the last year MBX Biosciences has showed a +318.19% increase.
What is MBX Biosciences market cap?▼
Today MBX Biosciences has the market capitalization of 2.93B
When is the next MBX Biosciences earnings date?▼
MBX Biosciences is going to release the next earnings report on November 05, 2026.
What were MBX Biosciences earnings last quarter?▼
MBX earnings for the last quarter are -0.78 USD per share, whereas the estimation was -0.63 USD resulting in a -23.32% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is MBX Biosciences revenue for the last year?▼
MBX Biosciences revenue for the last year amounts to 0 USD.
What is MBX Biosciences net income for the last year?▼
MBX net income for the last year is -86.97M USD.
How many employees does MBX Biosciences have?▼
As of September 02, 2026, the company has 63 employees.
In which sector is MBX Biosciences located?▼
MBX Biosciences operates in the Health & Wellness sector.
When did MBX Biosciences complete a stock split?▼
MBX Biosciences has not had any recent stock splits.
Where is MBX Biosciences headquartered?▼
MBX Biosciences is headquartered in CARMEL, United States.